These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 25400813)

  • 1. In vitro culturing of viable circulating tumor cells of urinary bladder cancer.
    Cegan M; Kolostova K; Matkowski R; Broul M; Schraml J; Fiutowski M; Bobek V
    Int J Clin Exp Pathol; 2014; 7(10):7164-71. PubMed ID: 25400813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perioperative search for circulating tumor cells in patients undergoing radical cystectomy for bladder cancer.
    Karl A; Tritschler S; Hofmann S; Stief CG; Schindlbeck C
    Eur J Med Res; 2009 Nov; 14(11):487-90. PubMed ID: 19948444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating tumor cells in localized prostate cancer: isolation, cultivation in vitro and relationship to T-stage and Gleason score.
    Kolostova K; Broul M; Schraml J; Cegan M; Matkowski R; Fiutowski M; Bobek V
    Anticancer Res; 2014 Jul; 34(7):3641-6. PubMed ID: 24982381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating tumor cells in pancreatic cancer patients: enrichment and cultivation.
    Bobek V; Gurlich R; Eliasova P; Kolostova K
    World J Gastroenterol; 2014 Dec; 20(45):17163-70. PubMed ID: 25493031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating tumour cells in patients with urothelial tumours: Enrichment and in vitro culture.
    Kolostova K; Cegan M; Bobek V
    Can Urol Assoc J; 2014 Sep; 8(9-10):E715-20. PubMed ID: 25408812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating tumor cells in patients with advanced urothelial carcinoma of the bladder: Association with tumor stage, lymph node metastases, FDG-PET findings, and survival.
    Abrahamsson J; Aaltonen K; Engilbertsson H; Liedberg F; Patschan O; Rydén L; Sjödahl G; Gudjonsson S
    Urol Oncol; 2017 Oct; 35(10):606.e9-606.e16. PubMed ID: 28676151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation Between Disease Stage and the Presence of Viable Circulating Tumor Cells in Endometrial Cancer.
    Kiss I; Kolostova K; Matkowski R; Jędryka M; Czekański A; Pavlasek J; Bobek V
    Anticancer Res; 2018 May; 38(5):2983-2987. PubMed ID: 29715128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility of a novel one-stop ISET device to capture CTCs and its clinical application.
    Chen F; Wang S; Fang Y; Zheng L; Zhi X; Cheng B; Chen Y; Zhang C; Shi D; Song H; Cai C; Zhou P; Xiong B
    Oncotarget; 2017 Jan; 8(2):3029-3041. PubMed ID: 27935872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and Characterization of CTCs from Patients with Cancer of a Urothelial Origin.
    Bobek V; Kolostova K
    Methods Mol Biol; 2018; 1655():275-286. PubMed ID: 28889392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of Urothelial Cancer Circulating Tumor Cells with a Novel Selection-Free Method.
    Chalfin HJ; Kates M; van der Toom EE; Glavaris S; Verdone JE; Hahn NM; Pienta KJ; Bivalacqua TJ; Gorin MA
    Urology; 2018 May; 115():82-86. PubMed ID: 29432873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The presence of circulating tumor cells does not predict extravesical disease in bladder cancer patients prior to radical cystectomy.
    Guzzo TJ; McNeil BK; Bivalacqua TJ; Elliott DJ; Sokoll LJ; Schoenberg MP
    Urol Oncol; 2012; 30(1):44-8. PubMed ID: 20005748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating tumor cells in different stages of colorectal cancer.
    Eliasova P; Pinkas M; Kolostova K; Gurlich R; Bobek V
    Folia Histochem Cytobiol; 2017; 55(1):1-5. PubMed ID: 28509310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection and cultivation of circulating tumor cells in malignant pleural mesothelioma.
    Bobek V; Kacprzak G; Rzechonek A; Kolostova K
    Anticancer Res; 2014 May; 34(5):2565-9. PubMed ID: 24778078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of circulating tumor cells in metastatic and clinically localized urothelial carcinoma.
    Flaig TW; Wilson S; van Bokhoven A; Varella-Garcia M; Wolfe P; Maroni P; Genova EE; Morales D; Lucia MS
    Urology; 2011 Oct; 78(4):863-7. PubMed ID: 21813167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Prognostic Role of Circulating Tumor Cells (CTC) in High-risk Non-muscle-invasive Bladder Cancer.
    Busetto GM; Ferro M; Del Giudice F; Antonini G; Chung BI; Sperduti I; Giannarelli D; Lucarelli G; Borghesi M; Musi G; de Cobelli O; De Berardinis E
    Clin Genitourin Cancer; 2017 Aug; 15(4):e661-e666. PubMed ID: 28188046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcripts of circulating tumor cells detected by a breast cancer-specific platform correlate with clinical stage in bladder cancer patients.
    Todenhöfer T; Hennenlotter J; Dorner N; Kühs U; Aufderklamm S; Rausch S; Bier S; Mischinger J; Schellbach D; Hauch S; Feniuk N; Bedke J; Gakis G; Stenzl A; Schwentner C
    J Cancer Res Clin Oncol; 2016 May; 142(5):1013-20. PubMed ID: 26910601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic dissemination of tumor cells during transurethral resection in patients with bladder tumor and its clinical relevance: A follow up study.
    Nayyar R; Saini S; Sharma A; Kurra S; Dogra PN
    Urol Oncol; 2021 Aug; 39(8):497.e17-497.e22. PubMed ID: 33766464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of circulating tumor cells using manually performed immunocytochemistry (MICC) does not correlate with outcome in patients with early breast cancer - Results of the German SUCCESS-A- trial.
    Jueckstock J; Rack B; Friedl TW; Scholz C; Steidl J; Trapp E; Tesch H; Forstbauer H; Lorenz R; Rezai M; Häberle L; Alunni-Fabbroni M; Schneeweiss A; Beckmann MW; Lichtenegger W; Fasching PA; Pantel K; Janni W;
    BMC Cancer; 2016 Jul; 16():401. PubMed ID: 27387743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characterization and heterogeneity of circulating tumor cells in breast cancer.
    Jakabova A; Bielcikova Z; Pospisilova E; Matkowski R; Szynglarewicz B; Staszek-Szewczyk U; Zemanova M; Petruzelka L; Eliasova P; Kolostova K; Bobek V
    Breast Cancer Res Treat; 2017 Dec; 166(3):695-700. PubMed ID: 28815327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of recurrence and progression in patients with T1G3 bladder cancer by gene expression of circulating tumor cells.
    Awadalla A; Abol-Enein H; Gabr MM; Hamam ET; Shokeir AA
    Urol Oncol; 2020 Apr; 38(4):278-285. PubMed ID: 31983531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.